Virtual meeting
Via Zoom
Description
This training reviews strategies for reducing communicable infectious diseases associated with injection drug use. We will explore testing strategies and linkage to care for those patients with diagnosed blood-borne pathogens; review bleaching/sterilization of injection paraphernalia, serosorting or sequential drug use to prevent infection of uninfected partners; and discuss pharmacological interventions for infection prevention, including nPEP and PrEP.
Intended audience
The entire multidisciplinary team providing treatment for substance use disorders in an office-based setting as well as anyone in a clinical or non-clinical position that is interested in learning about harm reduction.
Speakers
Annie Potter, MSN, MPH, FNP-C, CARN-AP (she/her)
Annie is a clinical nurse educator for Boston Medical Center's (BMC) Grayken Center for Addiction Training and Technical Assistance, a Nurse Practitioner in General Internal Medicine at BMC, and an assistant professor of medicine at Boston University Chobanian & Avedisian School of Medicine. Annie earned a master’s in nursing and public health from Johns Hopkins University and is certified as a Certified Addiction Registered Nurse - Advanced Practice (CARN-AP) through the Addictions Nursing Certification Board.
Kenneth Washington, Assistant Director AHOPE
Kenneth is an accomplished assistant director of AHOPE Needle Exchange, driven by a passion for harm reduction that stems from his work with at-risk youth. His lived experience has instilled in him a deep understanding of the challenges of racism, classism, and substance use, inspiring him to become a leader in the field.
Objectives
Following this training, participants will have the knowledge to:
- Recall communicable infections associated with injection drug use.
- Evaluate strategies to reduce the risk of communicable infections for people who inject drugs.
- Define the steps necessary to appropriately bleach injection drug equipment to reduce the risk of HIV transmission.
- Identify at least two pharmacological interventions for communicable disease acquisition among patients who inject drugs.
- Name at least three vaccines recommended for the prevention of infections for people who inject drugs.
Sponsored by
Boston Medical Center Grayken Center for Addiction TTA, Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS)
Funding for out of state attendees is provided by the Opioid Response Network (ORN).
Funding for this initiative was made possible (in part) by grant no. 1H79TI085588-02 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
Accreditation information
REQUIREMENTS for credit
- Register for training.
- Arrive/log into the Zoom meeting with the same email address associated with your addictiontraining.org user account no more than 10 minutes after designated start time for program.
- Identify yourself by typing your full name, ensuring your zoom name matches that used to register for training (or you cannot be marked on attendance).
- Be present through the end of the activity (i.e. until the designated end time of training).
- Complete evaluation within 2 weeks of program completion.
Please note this policy is strictly enforced for accreditation purposes. Participants will forfeit collection of credit and certificates of completion if more than 10 minutes of the training is missed.
